Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jun;24(6):355-9.

[An experimental study on the regulation of the expression of Th2 cytokines by nuclear factor-kappaB and protein kinase C in asthma]

[Article in Chinese]
Affiliations
  • PMID: 11802989

[An experimental study on the regulation of the expression of Th2 cytokines by nuclear factor-kappaB and protein kinase C in asthma]

[Article in Chinese]
W Xiong et al. Zhonghua Jie He He Hu Xi Za Zhi. 2001 Jun.

Abstract

Objective: To explore the role of nuclear factor-kappaB (NF-kappaB) in the signal pathway of protein kinase C (PKC) regulating the expression of Th2 cytokines, interleukin 4 (IL-4) and IL-5, by T lymphocyte in asthma.

Methods: 16 guinea pigs were randomly divided into 2 groups, normal control and asthmatic group. 16 asthmatic patients and 16 normal control persons also participated in the study. T lymphocytes were isolated and purified from blood of each guinea pig and each person and divided into 3 groups: cells of 1st group were control group, cells of 2nd group were stimulated with phorbol 12-myristate 13-acetate (PMA), cells of 3rd group were stimulated with PMA and pyrrolidine dithiocarbamate (PDTC). The expression of NF-kappaB were observed by immunocytochemical staining, the expression of IL-4 and IL-5 mRNA were observed by in situ hybridization staining, IL-4 and IL-5 protein in supernatants were measured by ELISA.

Results: The percentage of cells of active NF-kappaB, the percentage of positive cells of IL-4 and IL-5 mRNA, IL-4 and IL-5 protein in supernatants of asthmatic T lymphocyte stimulated with PMA were significantly higher than those of asthmatic T lymphocyte stimulated without PMA (q = 8.44 approximately 38.66, P < 0.01) and those of normal control T lymphocyte stimulated with PMA (q = 8.11 approximately 40.12, P < 0.01), and were significant reduced by PDTC (q = 6.50 approximately 35.63, P < 0.01). There were good positive correlation between the percentage of cells of active NF-kappaB and the percentage of positive cells of IL-4 and IL-5 mRNA (r = 0.60 approximately 0.82, P < 0.001, respectively), and also good positive correlation between the percentage of active NF-kappaB and IL-4 and IL-5 protein in supernatants (r = 0.42 approximately 0.70, P < 0.005 or < 0.001, respectively).

Conclusions: The active PKC of asthmatic T lymphocyte increasing the expression of IL-4 and IL-5 may be mediated by activating NF-kappaB, the activation of PKC-NF-kappaB signal pathway of T lymphocyte NF-kappab may play an important role in the pathogenesis of asthma.

PubMed Disclaimer

Similar articles

Publication types

MeSH terms